Atropos Health uses Arize AX to evaluate LLM-generated clinical evidence summaries in production.
Atropos's Auto Summary tool generates clinical evidence summaries across hundreds of studies a month but the team lacked visibility into quality at scale. It built a measurement framework on Arize AX using LLM-as-a-judge evaluation. The page gives no exact figures and says the team plans to narrow to one or two key metrics.
Arize AI is an ML and LLM observability platform, used by healthcare AI companies to evaluate and monitor LLM outputs in production
This sits in the Scale & Govern stage of the AI use-case lifecycle: Named examples from the tools pharma teams use to monitor, govern and keep validating an AI system once it is already live in production.
Published by Arize AI on its own site — read the original case study on arize.com ↗
Note: No quantified results on the page.
Related use cases
- 01How (And Why) AdeptID Achieved EU AI Act Compliance for Talent Matching
- 02Establishing Lifecycle AI Risk Management for Defense Operations
- 03Unifying AI Governance Across Global Operations at Scale
- 04Embedding & Automating AI Governance in Enterprise Workflows
- 05Operationalizing Responsible AI Governance for Global Business Units
- 06Mastercard and Credo AI: Scaling Generative AI Governance in the Financial Sector to Build Customer Trust